Cancer Treatment Holdings, Inc.
CTHZ
OTC PK
| 02/28/2003 | 11/30/2002 | 08/31/2002 | 05/31/2002 | 02/28/2002 | |
|---|---|---|---|---|---|
| Revenue | -- | 14.30K | 6.10K | 22.60K | 22.70K |
| Total Other Revenue | -- | 4.10K | 4.90K | -24.00K | 6.60K |
| Total Revenue | -- | 18.50K | 11.00K | -1.40K | 22.70K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 18.50K | 11.00K | -1.40K | 22.70K |
| SG&A Expenses | 95.90K | 248.70K | 117.50K | 191.80K | 113.20K |
| Depreciation & Amortization | 4.70K | 4.70K | 4.70K | 4.70K | 4.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 100.60K | 253.40K | 122.20K | 196.50K | 117.90K |
| Operating Income | -100.60K | -235.00K | -111.20K | -197.90K | -95.20K |
| Income Before Tax | -530.20K | -235.00K | -111.20K | -168.00K | -88.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -530.20K | -235.00K | -111.20K | -168.00K | -88.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -530.20K | -235.00K | -111.20K | -168.00K | -88.50K |
| EBIT | -100.60K | -235.00K | -111.20K | -197.90K | -95.20K |
| EBITDA | -95.90K | -230.30K | -106.50K | -193.20K | -90.50K |
| EPS Basic | -0.16 | -0.07 | -0.03 | -0.05 | -0.03 |
| Normalized Basic EPS | -0.02 | -0.04 | -0.02 | -0.03 | -0.02 |
| EPS Diluted | -0.16 | -0.07 | -0.03 | -0.05 | -0.03 |
| Normalized Diluted EPS | -0.02 | -0.04 | -0.02 | -0.03 | -0.02 |
| Average Basic Shares Outstanding | 3.34M | 3.34M | 3.34M | 3.34M | 3.34M |
| Average Diluted Shares Outstanding | 3.34M | 3.34M | 3.34M | 3.34M | 3.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
